The market is serving up a explosive mix of catalysts for listings like NeOnc Technologies Holdings (NASDAQ:NTHI), Wetour Robotics (NASDAQ:WETO), Kura Oncology (NASDAQ:KURA), Amylyx Pharmaceuticals (NASDAQ:AMLX), EyePoint Pharmaceuticals (NASDAQ:EYPT), and Super League Enterprise (NASDAQ:SLE).

NeOnc Technologies Holdings (NASDAQ: NTHI) has added another notable element to its increasingly active story: CEO Amir Heshmatpour is continuing to buy shares on the open market. Heshmatpour purchased 12,000 shares on August 14 at a weighted average price of $3.7883 and another 3,000 shares on August 17 at $4.3733, bringing the two latest purchases to 15,000 shares.

Here are today’s catalysts that are changing the narrative. $NTHI, $IPST, $OABI, $LLY, $HIVE, and $IVF

A Nasdaq listing can mean more than simply providing a larger venue for a company’s shares to trade. For NeOnc Technologies Holdings (NASDAQ:NTHI), its Nasdaq Global Market listing takes on added significance following the company’s encouraging Phase 2a results for NEO100.

Today’s stock market coverage illustrates two very different kinds of momentum. NeOnc (NASDAQ:NTHI), MDxHealth (NASDAQ:MDXH), and Capricor Therapeutics (NASDAQ:CAPR) are fundamentally driven healthcare stories, where clinical data, regulatory decisions, diagnostics adoption and cash runway determine whether today's enthusiasm can become a durable rerating, while Wetour Robotics (NASDAQ:WETO), Onfolio Holdings (NASDAQ:ONFO), and Creative Global Technology Holdings (NASDAQ: CGTL) are much more structure-sensitive.

NeOnc Technologies Holdings’ (NASDAQ: NTHI) August 12 headline was impossible to miss, but another interesting solution may be hiding in plain sight: while NeOnc produced encouraging data for one cancer drug, it also generated human clinical evidence around a non-invasive intranasal delivery strategy designed to reach the brain without relying on conventional systemic delivery across the blood-brain barrier.

The market is serving up several very different stories converging into one high-energy trading session. Rocky Mountain Chocolate Factory (NASDAQ:RMCF) is suddenly in play after disclosing that its board is exploring strategic alternatives that could include a sale, merger or going-private transaction. NeOnc Technologies Holdings (NASDAQ:NTHI) delivered a major clinical catalyst with NEO100 beating the six-month progression-free-survival benchmark by nearly 2.5 times. Meanwhile, Boxlight (NASDAQ:BOXL) is trying to buy itself additional financial runway, while Super Micro Computer (NASDAQ:SMCI) and CoreWeave (NASDAQ:CRWV) are showing just how enormous the AI infrastructure opportunity has become. Add OFA Group (NASDAQ:OFAL) to the mix after its recent 1-for-10 reverse split, and the tape is packed with the kind of catalysts that can produce outsized moves.

NeOnc Technologies Holdings (NASDAQ:NTHI) reported encouraging Phase 2a results for intranasal NEO100 in patients with recurrent IDH1-mutant high-grade glioma, with 48.9% of patients remaining progression-free at six months, nearly 2.5 times the 20% historical benchmark, while median overall survival reached approximately 26 months.

Planet Green Holdings (NYSEAMERICAN:PLAG), NeOnc Technologies (NASDAQ:NTHI), and Quantum Corporation (NASDAQ:QMCO) made nice runs since our midday coverage. While AbCellera Biologics (NASDAQ:ABCL) and Bank of America (NYSE:BAC) were among the notable names reaching new 52-week highs Tuesday.